Bioprocessing Antibody Drug Conjugates in Biopharma: Making Magic Bullets

Article   Mar 28, 2017 | Original Article by Adam Tozer Ph.D

 
Bioprocessing Antibody Drug Conjugates in Biopharma: Making Magic Bullets

ADCs are the next generation of cancer therapies. Credit: Lonza

 
 
 

RELATED ARTICLES

Shining a Light on Drug Development: Revolutionizing Radiolabeling

Article

Researchers have developed a revolutionary method for making radioactive molecules. This new technique means that new medicines may reach patients much faster than ever before.

READ MORE

Diamond Light Source in its Anniversary Year

Article

The UK’s national synchrotron, Diamond Light Source, celebrates its double anniversary this year. 2017 sees them mark 15 years since the company was formed, and on the 19th October, they commemorated 10 years since their official opening by Her Majesty the Queen.

READ MORE

New Crystal Structure of (Ph)PINK1 Aids Understanding of Early Onset Parkinson’s

Article

Scientists have determined the crystal structure of PhPINK1 bound to it's substrate ubiquitin. Mutations of PINK1 are associated with early onset Parkinson's disease and it is expected that this information will help the design of Parkinson's therapeutics.

READ MORE

 

Comments | 1 ADD COMMENT

Ana Aitawa | Oct 03, 2017

iHealthcareAnalyst, Inc. - The global antibody drug conjugates market expected to reach US$ 4.6 billion by 2021, growing at CAGR 30.2% over the forecast period 2017-2021, owing to increasing drug prices and rapid approval of new treatments. Visit Antibody Drug Conjugates Market by Marketed Drugs – Adcetris or SGN-35 (Brentuximab vedotin), Kadcyla or T-DM1 (Trastuzumab emtansine), Pipeline Drugs – Rova-T or SC16LD6.5 (Rovalpituzumab tesirine), CDX-011 (Glembatumumab vedotin), Besponsa or CMC-544 (Inotuzumab ozogamicin), IMGN853 (Mirvetuximab soravtansine), SGN-CD33A (Vadastuximab talirine) and Forecast 2017-2021 https://www.ihealthcareanalyst.com/report/antibody-drug-conjugates-market/


Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE